Cite

HARVARD Citation

    Fischer, M. et al. (2017). RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations. Scientific reports. 7 (1), pp. 1-9. [Online]. 
  
Back to record